Morgan Stanley Maintains Equal-Weight on Amgen, Raises Price Target to $410
Benzinga Newsdesk 8 hours ago
Analyst RatingsNewsPrice TargetHot
Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $359 to $410.
Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $359 to $410.